Involvement of dopamine receptors and β-arrestin in metamphetamine-induced inclusions formation in pc12 cells

Journal of Neurochemistry

Volumn 105, Issue 5, 2008, Pages 1939-1947

  Fornai, Francesco ^b,c   Lenzi, Paola ^b   Capobianco, Loredana ^c   Iacovelli, Luisa ^d   Scarselli, Pamela ^c   Lazzeri, Gloria ^b   De Blasi, Antonio ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c IRCCS NEUROMED   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Arrestin; Dopamine receptors; Metamphetamine; Parkinson's disease; Ubiquitin proteasome system; Ubiquitination

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ARRESTIN; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; HYBRID PROTEIN; METHAMPHETAMINE; MUTANT PROTEIN; PROTEASOME; UBIQUITIN;

ANIMAL CELL; ARTICLE; AUTOPHAGY; BRAIN NERVE CELL; CELL MEMBRANE; CONTROLLED STUDY; DRUG INHIBITION; ELECTRON MICROSCOPY; GENETIC TRANSFECTION; LAMELLAR BODY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; ARRESTINS; INCLUSION BODIES; METHAMPHETAMINE; PC12 CELLS; RATS; RECEPTORS, DOPAMINE;

EID: 43549117036     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05284.x     Document Type: Article

References (27)

1. Beaulieu J. M., Gainetdinov R. R. Caron M. G. (2007) The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol. Sci. 28, 166 172.
2. Caricasole A., Ferraro F., Iacovelli L., Barletta E., Caruso A., Melchiorri D., Terstappen G. C. Nicoletti F. (2003) Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins. J. Biol. Chem. 278, 37024 37031.
3. Ciechanover A., Orian A. Schwartz A. L. (2000) Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioassays 22, 442 451.
4. De Blasi A., Capobianco L., Iacovelli L., Lenzi P., Ferrucci M., Lazzeri G., Fornai F. Picascia A. (2003) Presence of β-arrestin in cellular inclusions in metamphetamine-treated PC12 cells. Neurol. Sci 24, 164 165.
5. De Wire S. M., Ahn S., Lefkowitz R. J. Shenoy S. K. (2007) Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69, 483 510.
6. Ferguson S. S. (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling Pharmacol. Rev. 53, 1 24.
7. Fornai F., Lenzi P., Gesi M. et al. (2003) Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition J. Neurosci. 23, 8955 8966.
8. Fornai F., Lenzi P., Frenzilli G. et al. (2004a) DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy). Psychopharmacology (Berl). 173, 353 363.
9. Fornai F., Lenzi P., Gesi M. et al. (2004b) Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J. Neurochem. 88, 114 123.
10. Goodman Jr. O. B., Krupnick J. C., Santini F., Gurevich V. V., Penn R. B., Gagnon A. W., Keen J. H. Benovic J. L. (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383, 447 450.
11. Iacovelli L., Salvatore L., Capobianco L. et al. (2003) Role of G protein-coupled receptor kinase 4 and beta-arrestin 1 in agonist-stimulated metabotropic glutamate receptor 1 internalization and activation of mitogen-activated protein kinases. J. Biol. Chem. 278, 12433 12442.
12. Jakel R. J. Maragos W. F. (2000) Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends Neurosci. 23, 239 245.
13. Keller J. N., Huang F. F., Dimayuga E. R. Maragos W. F. (2000) Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radic. Biol. Med. 29, 1037 1042.
14. Lazarovici P., Jiang H. Fink Jr. D. (1998) The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21(ras) G protein, and pp60(c-src) cytoplasmic tyrosine kinase. Mol. Pharmacol. 54, 547 558.
15. Lazzeri G., Lenzi P., Busceti C. L., Ferrucci M., Falleni A., Bruno V., Paparelli A. Fornai F. (2007) Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons. J. Neurochem. 101, 1414 1427.
16. Maragos W. F., Jakel R. J., Pang Z. Geddes J. W. (1998) 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitroproprionic acid lesions. Exp. Neurol. 154, 637 644.
17. Maragos W. F., Jakel R. J., Chesnut M. D., Geddes J. W. Dwoskin L. P. (1999) Does dopamine contribute to striatal damage caused by impaired mitochondrial function? Ann. NY Acad. Sci. 893, 345 349.
18. Martin N. P., Lefkowitz R. J. Shenoy V. (2003) Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination. J. Biol. Chem. 278, 45954 45959.
19. Parruti G., Peracchia F., Sallese M., Ambrosini G., Masini M., Rotilio D. De Blasi A. (1993) Molecular analysis of human beta-arrestin-1: cloning, tissue distribution, and regulation of expression. Identification of two isoforms generated by alternative splicing. J. Biol. Chem. 268, 9753 9761.
20. Premont R. T. Gainetdinov R. R. (2007) Physiological roles of G protein-coupled receptor kinases and arrestins. Annu. Rev. Physiol. 69, 511 534.
21. Seiden L. S. Sabol K. E. (1996) Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res. Monogr. 163, 251 276.
22. Shenoy S. K. Lefkowitz R. J. (2003) Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. J. Biol. Chem. 278, 14498 14506.
23. Shenoy S. K. Lefkowitz R. J. (2005) Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.J. Biol. Chem. 280, 15315 15324.
24. Shenoy S. K., McDonald P. H., Konhout T. A. Lefkowitz R. J. (2001) Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294, 1307 1313.
25. Shenoy S. K., Barak L. S., Xiao K., Ahn S., Berthouze M., Shukla A. K., Luttrell L. M. Lefkowitz R. J. (2007) Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J. Biol. Chem. 40, 29549 29562.
26. Stefanis L., Larsen K. E., Rideout H. J., Sulzer D. Greene L. A. (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J. Neurosci. 21, 9549 9570.
27. Thompson P. M., Hayashi K. M., Simon S. L. et al. (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 24, 6028 6036.